The continual growth in clinical application of NGS as well as sequencing of whole or targeted genomes has presented a bright prospect for the growth of global Next Generation Sequencing (NGS) market. Reduction of costs associated with sequencing has further led to wide scale application of such techniques.
Major Key Players of the Next generation sequencing (NGS) Market are:
Agilent Technologies, 10x Genomics, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Eurofins Scientific, Pacific Biosciences of California, Inc., BGI, Illumina, Inc., F. Hoffmann-La Roche AG, among others.
The advent of NGS has led to significant changes in the scientific approach utilized for both clinical and research applications. Both RNA & DNA sequencing have been proven to be extremely useful for studying evolutionary relationships, mutation, sequence variation and other vital information associated with genes. The clinical applications of which has been pivotal in diagnosing germline diseases and understanding the genetic basis of various hereditary or chronic diseases among others. The growing incidences of several clinical ailments has directly contributed to the extensive adoption of NGS and other sequencing techniques, to obtain better understanding of the diseases and formulate necessary therapies for the same.
The Next generation sequencing (NGS) Market is segmented on the basis of Services, Technology, Application and region.
Major Services of Next generation sequencing (NGS) Market covered are:
- Pre-Sequencing Products & Service
- Sequencing Services
- Data Analysis
- Storage
- Management
Major Technology of Next generation sequencing (NGS) Market covered are:
- Sequencing By Synthesis Ion Semiconductor Sequencing
- Single-Molecule Real-Time Sequencing
Major Services of Next generation sequencing (NGS) Market covered are:
- Diagnostics
- Drug Discovery
No comments:
Post a Comment